Sundarakumar Jonas S, Stezin Albert, Menesgere Abhishek L, Ravindranath Vijayalakshmi
Centre for Brain Research, Indian Institute of Science, C.V. Raman Avenue, Bangalore 560012, India.
EClinicalMedicine. 2022 Apr 19;47:101395. doi: 10.1016/j.eclinm.2022.101395. eCollection 2022 May.
Despite the growing evidence of metabolic syndrome as a major risk factor for cardiovascular and cerebrovascular disease, there are limited studies from India on its prevalence, especially in the aging population. We aimed to estimate the prevalence of metabolic syndrome and associated comorbidities in two prospective, aging cohorts from rural and urban India.
In these two parallel, prospective, aging (≥ 45 years) cohorts, the samples included 2171 people from rural India (Srinivaspura Aging, Neuro Senescence and COGnition, SANSCOG cohort; April 23, 2018 to Sept 25, 2021) and 332 people from urban India (Tata Longitudinal Study on Aging, TLSA cohort; July 8, 2015 to Oct 23, 2021). Using cross-sectional data from baseline clinical and biochemical assessments, we calculated metabolic syndrome prevalence using two well established criteria, namely consensus criteria and National Cholesterol Education Program - Adult Treatment Panel III (NCEP-ATP III) criteria; further, rural-urban, gender, and age-wise differences were compared.
Proportions of metabolic syndrome were 46.2 and 54.8% as per consensus criteria in rural and urban participants, respectively; corresponding numbers using NCEP-ATP III criteria were 40.3 and 45.1%. Rural-dwelling older adults had a significantly lesser prevalence of all individual metabolic syndrome parameters except impaired triglycerides and high-density lipoprotein levels. Rural women had a significantly higher prevalence of metabolic syndrome than rural men, whereas there was no significant difference among urban participants. We did not observe any consistent age-wise trend when comparing both cohorts. There was high burden of comorbidities among both groups, mostly undiagnosed in rural participants.
Roughly one in two older adults had metabolic syndrome, urban significantly more than rural, reaching an alarming 63.1% among urban participants aged 65-74 years. The very high prevalence of undiagnosed co-morbidities among rural adults is extremely concerning, calling for urgent public health measures in this marginalised and health-disparate population.
SANSCOG study is funded through the Centre for Brain Research (CBR), Indian Institute of Science (IISc) by Pratiksha Trust, the philanthropic arm of Mr. Kris Gopalakrishnan. TLSA is funded by Tata Trusts.
尽管越来越多的证据表明代谢综合征是心血管和脑血管疾病的主要危险因素,但印度关于其患病率的研究有限,尤其是在老年人群中。我们旨在估计来自印度农村和城市的两个前瞻性老年队列中代谢综合征及相关合并症的患病率。
在这两个平行的前瞻性老年(≥45岁)队列中,样本包括来自印度农村的2171人(Srinivaspura衰老、神经衰老与认知研究,SANSCOG队列;2018年4月23日至2021年9月25日)和来自印度城市的332人(塔塔衰老纵向研究,TLSA队列;2015年7月8日至2021年10月23日)。利用基线临床和生化评估的横断面数据,我们使用两个公认的标准,即共识标准和美国国家胆固醇教育计划成人治疗小组第三次报告(NCEP-ATP III)标准,计算代谢综合征患病率;此外,还比较了城乡、性别和年龄方面的差异。
根据共识标准,农村和城市参与者中代谢综合征的比例分别为46.2%和54.8%;使用NCEP-ATP III标准的相应数字分别为40.3%和45.1%。农村老年成年人除甘油三酯和高密度脂蛋白水平受损外,所有个体代谢综合征参数的患病率均显著较低。农村女性代谢综合征的患病率显著高于农村男性,而城市参与者之间没有显著差异。在比较两个队列时,我们没有观察到任何一致的年龄趋势。两组中合并症负担都很高,农村参与者中大多未被诊断出来。
大约每两名老年人中就有一人患有代谢综合征,城市患病率显著高于农村,在65-74岁的城市参与者中达到惊人的63.1%。农村成年人中未被诊断出的合并症患病率极高,令人极为担忧,这就需要对这个边缘化且存在健康差异的人群采取紧急公共卫生措施。
SANSCOG研究由印度科学研究所(IISc)脑研究中心(CBR)通过Pratiksha信托基金资助,Pratiksha信托基金是Kris Gopalakrishnan先生的慈善机构。TLSA由塔塔信托基金资助。